Journal article
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
- Abstract:
-
OBJECTIVE: The most widely studied positron emission tomography ligand for in vivo beta-amyloid imaging is (11)C-Pittsburgh compound B ((11)C-PIB). Its availability, however, is limited by the need for an on-site cyclotron. Validation of the (18)F-labeled PIB derivative (18)F-flutemetamol could significantly enhance access to this novel technology. METHODS: Twenty-seven patients with early-stage clinically probable Alzheimer disease (AD), 20 with amnestic mild cognitive impairment (MCI), and...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Annals of neurology
- Volume:
- 68
- Issue:
- 3
- Pages:
- 319-329
- Publication date:
- 2010-09-01
- DOI:
- EISSN:
-
1531-8249
- ISSN:
-
0364-5134
- Source identifiers:
-
429451
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:429451
- UUID:
-
uuid:14fb3a8c-558c-4b7c-888f-b857d519e62b
- Local pid:
- pubs:429451
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2010
If you are the owner of this record, you can report an update to it here: Report update to this record